NEW YORK (Associated Press) – Schering-Plough Corp. has many promising drugs in late testing and years of patent protection for its key products, unlike most of its competitors, Chief Executive Fred Hassan told analysts Monday.
The drugmaker has five “star” compounds in late testing or about to be launched, plus 13 other experimental drugs it believes could be best or first in class.
“We believe we’re hitting the sweet spot on R&D and patent exclusivity” Read the rest of this entry »
Tags: competitors, Over, Pipeline, Plough, Schering, touts Posted in Health, News | No Comments »
(Adds new details throughout.)
KENILWORTH, N.J. -(Dow Jones)-
Schering-Plough Corp.
(SGP) plans to file for
regulatory approval of five new drugs in 2009, the drug maker’s executives said
Monday.
The company will file for regulatory green lights for the fertility drug
Corifollitropin alfa; a contraceptive called Nomac/E2; anti-HIV drug Vicriviroc;
a combination of the drugs mometasone and formoterol that would treat asthma and
another respiratory Read the rest of this entry »
Tags: 2009, applications, Drug, Schering, sees, UPDATE Posted in Health, News | No Comments »
October 21, 2008, 8:00 AM ET
Janet M. Barth – VP, IR
Robert J. Bertolini – EVP and CFO
Carrie S. Cox – EVP and President, Global Pharmaceuticals
Thomas P. Koestler – EVP and President, Schering-Plough Research Institute
Chris Schott – J.P. Morgan
Good morning my name is Marsha and I will be your conference operator today. At this time I would like to welcome everyone to the Schering-Plough Third Quarter Earnings Conference Call. All lines Read the rest of this entry »
Tags: 2008, Call, Conference, Corp, Earnings, Plough, Schering, Transcript Posted in Health, News | No Comments »